These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 5567771

  • 1. Creatine phosphokinase in facioscapulohumeral muscular dystrophy.
    Hughes BP.
    Br Med J; 1971 Aug; 3(5772):464-5. PubMed ID: 5567771
    [Abstract] [Full Text] [Related]

  • 2. Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease.
    Jackson CE, Strehler DA.
    Pediatrics; 1968 Feb; 41(2):495-502. PubMed ID: 5637795
    [No Abstract] [Full Text] [Related]

  • 3. Poikiloderma atrophicans vasculare associated with muscular dystrophy.
    Woolfson H, McQueen A.
    Arch Dermatol; 1973 Jan; 107(1):115-7. PubMed ID: 4682534
    [No Abstract] [Full Text] [Related]

  • 4. Infantile facioscapulohumeral muscular dystrophy: new observations.
    Bailey RO, Marzulo DC, Hans MB.
    Acta Neurol Scand; 1986 Jul; 74(1):51-8. PubMed ID: 3766116
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The facio-scapulo-limb (or the facioscapulohumeral) type of muscular dystrophy. Clinical and genetic study of 200 cases.
    Kazakov VM, Bogorodinsky DK, Znoyko ZV, Skorometz AA.
    Eur Neurol; 1974 Jul; 11(4):236-60. PubMed ID: 4854830
    [No Abstract] [Full Text] [Related]

  • 7. Linkage studies in autosomal dominant facioscapulohumeral muscular dystrophy.
    Padberg G, Eriksson AW, Volkers WS, Bernini L, Van Loghem E, Meera Khan P, Nijenhuis LE, Pronk JC, Schreuder GM.
    J Neurol Sci; 1984 Sep; 65(3):261-8. PubMed ID: 6593433
    [Abstract] [Full Text] [Related]

  • 8. Permanent paralysis of the atrium in a patient with facioscapulohumeral muscular dystrophy.
    Baldwin BJ, Talley RC, Johnson C, Nutter DO.
    Am J Cardiol; 1973 May; 31(5):649-53. PubMed ID: 4698137
    [No Abstract] [Full Text] [Related]

  • 9. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. I. Analysis of results from 29 studies.
    Gale AN, Murphy EA.
    J Chronic Dis; 1978 Feb; 31(2):101-9. PubMed ID: 659567
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Malate dehydrogenase activity in patients with different forms of progressive muscular dystrophy].
    Gil'manov VKh.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 Feb; 70(9):1309-12. PubMed ID: 5511109
    [No Abstract] [Full Text] [Related]

  • 12. Letter: Serum-creatine-kinase levels in carriers of Becker muscular dystrophy.
    Skinner R, Emery AE.
    Lancet; 1974 Oct 26; 2(7887):1023-4. PubMed ID: 4138389
    [No Abstract] [Full Text] [Related]

  • 13. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR, Ziter FA, Wu LH, Wu JT.
    Neurology; 1978 Oct 26; 28(10):1047-50. PubMed ID: 570660
    [Abstract] [Full Text] [Related]

  • 14. Carrier detection in X-linked muscular dystrophy.
    Walton JN.
    J Genet Hum; 1969 Oct 26; 17(3):497-510. PubMed ID: 5387424
    [No Abstract] [Full Text] [Related]

  • 15. Reconstruction in Landouzy-Dejerine progressive muscular dystrophy. Case report.
    Cocke WM, Davis WG.
    Plast Reconstr Surg; 1971 Jul 26; 48(1):77-9. PubMed ID: 5556722
    [No Abstract] [Full Text] [Related]

  • 16. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
    László A, Salgó L.
    Orv Hetil; 1981 Jun 14; 122(24):1453-6. PubMed ID: 7290660
    [No Abstract] [Full Text] [Related]

  • 17. Limb-girdle musclar dystrophy: its larger significance.
    Pediatrics; 1968 Feb 14; 41(2):382-4. PubMed ID: 5637790
    [No Abstract] [Full Text] [Related]

  • 18. Facioscapulohumeral dystrophy presenting in infancy with facial diplegia and sensorineural deafness.
    Korf BR, Bresnan MJ, Shapiro F, Sotrel A, Abroms IF.
    Ann Neurol; 1985 May 14; 17(5):513-6. PubMed ID: 4004175
    [Abstract] [Full Text] [Related]

  • 19. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K.
    Nagoya Med J; 1972 Feb 14; 17(3):203-16. PubMed ID: 5050757
    [No Abstract] [Full Text] [Related]

  • 20. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. II. Review of methods of assay and factors which may be relevant in the interpretation of serum creatine phosphokinase activity.
    Gale AN, Murphy EA.
    J Chronic Dis; 1979 Feb 14; 32(9-10):639-51. PubMed ID: 489704
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.